Sector pending / Electromedical and Electrotherapeutic ApparatusUpdated 2026-05-10 22:07 UTC

FRA/RMEA stock hub

FRA/RMEA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/RMEAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

25.5B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/RMEA

In the news

Latest news · FRA/RMEA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.3

P25 n/aP50 n/aP75 n/a

Trailing P/E19.3

P25 n/aP50 n/aP75 n/a

ROE25.2

P25 n/aP50 n/aP75 n/a

ROIC26.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/RMEA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

225

Groups with data

Currency

USD

Showing 225 of 225 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	10,600
Employees Change	620%
Employees Change Percent	6.21
Enterprise value	EUR 24.8B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Electromedical and Electrotherapeutic Apparatus
Last refreshed	2026-05-10
Market cap	EUR 25.5B
Price	EUR 17.7
Price currency	EUR
Rev Per Employee	453,106.08x
Sic	3845
Symbol	fra/RMEA
Website	https://www.resmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.17%
EV Earnings	18.81x
EV/EBIT	15.11x
EV/EBITDA	13.49x
EV/FCF	16.29x
EV/Sales	5.27x
FCF yield	5.97%
Forward P/E	17.33x
P/B ratio	4.53x
P/E ratio	19.33x
P/S ratio	5.31x
PE Ratio10 Y	38.74x
PE Ratio3 Y	27.5x
PE Ratio5 Y	37.8x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.76%
EBITDA Margin	38.27%
FCF margin	31.68%
Gross margin	62.18%
Gross Profit	EUR 3B
Gross Profit Growth	15.51%
Gross Profit Growth Q	16.15%
Gross Profit Growth3 Y	14.58%
Gross Profit Growth5 Y	13.24%
Net Income	EUR 1.3B
Net Income Growth	15.71%
Net Income Growth Q	9.23%
Net Income Growth3 Y	20.76%
Net Income Growth5 Y	27.15%
Pretax Margin	34.37%
Profit Margin	27.44%
Profit Per Employee	EUR 124,332
ROA	14.72
Roa5y	12.79
ROCE	25.9
ROE	25.25
Roe5y	23.02
ROIC	26.9
Roic5y	20.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	15.39%
Cagr1y	-15.15%
Cagr3y	-3.44%
Cagr5y	3.56%
Div CAGR10	8.31%
Div CAGR3	6.12%
Div CAGR5	8.4%
EPS Growth	16.39
EPS Growth Q	10.48
EPS Growth3 Y	20.96
EPS Growth5 Y	27.08
FCF Growth	11.82%
FCF Growth Q	-6.7%
FCF Growth3 Y	60.86%
FCF Growth5 Y	18.6%
OCF Growth	14.34%
OCF Growth Q	-4.24%
OCF Growth10 Y	14.12%
OCF Growth3 Y	52.27%
OCF Growth5 Y	17.59%
Revenue Growth	10.28x
Revenue Growth Q	10.81x
Revenue Growth3 Y	11.31x
Revenue Growth5 Y	12.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.68
Assets	EUR 7.6B
Cash	EUR 1.4B
Current Assets	EUR 3.4B
Current Liabilities	EUR 1.1B
Debt	EUR 731.3M
Debt EBITDA	EUR 0.39
Debt Equity	EUR 0.13
Debt FCF	EUR 0.48
Equity	EUR 5.6B
Liabilities	EUR 2B
Long Term Assets	EUR 4.2B
Long Term Liabilities	EUR 842.4M
Net Cash	EUR 708.9M
Net Cash By Market Cap	EUR 2.78
Net Cash Growth	779.44%
Net Debt EBITDA	EUR -0.39
Net Debt Equity	EUR -0.13
Net Debt FCF	EUR -0.47
Tangible Book Value	EUR 2.6B
Tangible Book Value Per Share	EUR 18.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.01
Inventory Turnover	2.24
Net Working Capital	EUR 1.2B
Quick ratio	2
Working Capital	EUR 2.4B
Working Capital Turnover	EUR 1.93

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.62%
Dividend Growth	5.13%
Dividend Growth Years	1%
Dividend per share	EUR 0.2
Dividend Years	15
Dividend Yield	1.14%
Ex Div Date	2026-02-11
Last Dividend	EUR 0.05
Payout Frequency	Quarterly
Payout Ratio	22.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	318.52%
1Y total return	-15.14%
200-day SMA	21.41
3Y total return	-9.98%
50-day SMA	19.27
50-day SMA vs 200-day SMA	50under200
5Y total return	19.09%
All Time High	25.6
All Time High Change	-30.86%
All Time High Date	2021-09-10
All Time Low	3.05
All Time Low Change	479.76%
All Time Low Date	2014-03-25
ATR	0.22
Ch YTD	-14.9
High	17.7
High52	24.6
High52 Date	2025-08-25
High52ch	-28.05%
Low	17.7
Low52	17.3
Low52 Date	2026-05-04
Low52ch	2.31%
Ma50ch	-8.13%
Price vs 200-day SMA	-17.31%
RSI	37.74
RSI Monthly	40.2
RSI Weekly	32.15
Sharpe ratio	-0.71x
Sortino ratio	-0.76
Total Return	1.76%
Tr YTD	-14.71
Tr1m	-6.35%
Tr1w	2.31%
Tr3m	-18.62%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 1.7B
Operating Income Growth	19.41
Operating Income Growth Q	18.63
Operating Income Growth3 Y	19.68
Operating Income Growth5 Y	16.44
Operating margin	34.76

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	144,169,809%
Net Borrowing	-8,479,620
Shares Insiders	0.52%
Shares Institutions	76.08%
Shares Qo Q	-0.44%
Shares Yo Y	-0.62%
Short Ratio	10.14

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 1.4B
Average Volume	0x
Bv Per Share	38.82
CAPEX	EUR -117.7M
Ch10y	266.5
Ch1m	-6.35
Ch1w	2.31
Ch1y	-15.71
Ch3m	-18.81
Ch3y	-14.08
Ch5y	12.03
Ch6m	-16.51
Change	0.57%
Change From Open	0
Close	17.6
Days Gap	0.57
Depreciation Amortization	165,033,756.3
Earnings Date	2026-04-30
EBIT	EUR 1.7B
EBITDA	EUR 1.8B
EPS	EUR 8.99
F Score	6
FCF	EUR 1.5B
FCF EV Yield	6.14x
Financing CF	-787,293,310
Fiscal Year End	June
Founded	1,989
Goodwill	2,580,463,688.8
Graham Number	8.97557
Graham Upside	-49.29
Income Tax	EUR 332.8M
Investing CF	-256,079,865
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Lynch Fair Value	EUR 22.89
Lynch Upside	29.3
Ma150	20.75
Ma150ch	-14.68%
Ma20	18.26
Ma20ch	-3.07%
Net CF	631,222,675
Next Earnings Date	2026-07-30
Open	17.7
P FCF Ratio	16.75
P OCF Ratio	15.55
Payment Date	2026-03-19
Ppne	617,803,066.2
Price Date	2026-05-08
Price EBITDA	EUR 13.86
Ptbv Ratio	9.72
Relative Volume	20x
Revenue	4,802,924,400x
SBC By Revenue	1.84x
Share Based Comp	88,153,239
Tax By Revenue	6.93x
Tax Rate	20.16%
Tr6m	-16.12%
Volume	0
Z Score	12.56

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/RMEA dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$0.20 annual per share

Payout ratio

+22.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+8.4%

1 consecutive years of growth

Total shareholder yield

+1.8%

Next ex-dividend date: 2026-02-11

Performance

FRA/RMEA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/RMEA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+76.1%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/RMEA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.7

Neutral momentum band

Price vs 200-day MA

-17.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.71

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/RMEA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/RMEA stock rating?

fra/RMEA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/RMEA analysis?

The full report lives at /stocks/fra/RMEA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/RMEA?

The latest report frames fra/RMEA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/RMEA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.